BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 19422586)

  • 1. Predictors of syncope in patients with hypertrophic cardiomyopathy.
    Haghjoo M; Faghfurian B; Taherpour M; Fazelifar AF; Mohammadzadeh S; Alizadeh A; Sadr-Ameli MA
    Pacing Clin Electrophysiol; 2009 May; 32(5):642-7. PubMed ID: 19422586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.
    Biagini E; Coccolo F; Ferlito M; Perugini E; Rocchi G; Bacchi-Reggiani L; Lofiego C; Boriani G; Prandstraller D; Picchio FM; Branzi A; Rapezzi C
    J Am Coll Cardiol; 2005 Oct; 46(8):1543-50. PubMed ID: 16226182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk of syncope in hypertrophic cardiomyopathy: a multivariate analysis of prognostic variables].
    Nienaber CA; Hiller S; Spielmann RP; Geiger M; Kuck KH
    Z Kardiol; 1990 Apr; 79(4):286-96. PubMed ID: 2356642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of arrhythmic events during second day monitoring in patients with normal first day Holter recordings.
    Arya A; Haghjoo M; Khosrawi A; Emkanjoo Z; Sadr-Ameli MA
    Indian Heart J; 2005; 57(3):241-4. PubMed ID: 16196182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syncope and risk of sudden death in hypertrophic cardiomyopathy.
    Spirito P; Autore C; Rapezzi C; Bernabò P; Badagliacca R; Maron MS; Bongioanni S; Coccolo F; Estes NA; Barillà CS; Biagini E; Quarta G; Conte MR; Bruzzi P; Maron BJ
    Circulation; 2009 Apr; 119(13):1703-10. PubMed ID: 19307481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy.
    Olivotto I; Montereggi A; Mazzuoli F; Cecchi F
    G Ital Cardiol; 1999 Jan; 29(1):11-9. PubMed ID: 9987042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment?
    Zecchin M; Di Lenarda A; Gregori D; Merlo M; Pivetta A; Vitrella G; Sabbadini G; Mestroni L; Sinagra G
    Pacing Clin Electrophysiol; 2008 Mar; 31(3):290-9. PubMed ID: 18307623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy.
    Thaman R; Gimeno JR; Murphy RT; Kubo T; Sachdev B; Mogensen J; Elliott PM; McKenna WJ
    Heart; 2005 Jul; 91(7):920-5. PubMed ID: 15958362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
    Becker R; Haass M; Ick D; Krueger C; Bauer A; Senges-Becker JC; Voss F; Hilbel T; Niroomand F; Katus HA; Schoels W
    Basic Res Cardiol; 2003 Jul; 98(4):259-66. PubMed ID: 12835955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of cardiac events in patients with isolated syncope and negative electrophysiologic study.
    Da Costa A; Gulian JL; Romeyer-Bouchard C; Messier M; Zarqane N; Samuel B; Khiel A; Isaaz K
    Int J Cardiol; 2006 Apr; 109(1):28-33. PubMed ID: 15975670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
    Adabag AS; Maron BJ; Appelbaum E; Harrigan CJ; Buros JL; Gibson CM; Lesser JR; Hanna CA; Udelson JE; Manning WJ; Maron MS
    J Am Coll Cardiol; 2008 Apr; 51(14):1369-74. PubMed ID: 18387438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
    Pokorski RJ
    J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic dilated cardiomyopathy: prognostic significance of electrocardiographic and electrophysiologic findings in the nineties.
    Morgera T; Di Lenarda A; Sabbadini G; Rakar S; Carniel E; Driussi M; Sinagra G
    Ital Heart J; 2004 Aug; 5(8):593-603. PubMed ID: 15554030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
    J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.